PharmCAT.NET

Биостатистика, фармакокинетика и клинические исследования.

  • Домашняя страница
    • О сайте
  • Материалы
    • Быстрые команды R Project
    • Ссылки
  • Инструменты
    • Рандомизационный список
  • Блог
    • Статистика
    • Phoenix WinNonlin
    • IT
    • Путевые заметки
  • Контакты
    • Контактные данные
    • Консультации
    • Конфиденциальность
  • Профиль
    • Войти
    • Зарегистрироваться

Julia:ReplicateBE – release 0.2.0

Опубликовано 26 октября, 201926 октября, 2019 frozencat

doiGitHub

Вот и подоспел релиз 0.2.0 для оценки параметров смешанной модели репликативного дизайна биоэквивалентности по методу С (EMA) – FDA model.

 

Рубрики: IT, Julia, Mixed Model, Биоэквивалентность

Навигация по записям

Предыдущая запись: ClinicalTrialUtilities: обзор
Следующая запись: Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4

Свежие записи

  • Оценка данных вариации литературных источников для определения объема выборки клинических исследований биоэквивалентности
  • Long WS Wide: или про то, как выполнить анализ разницы изменений между группами
  • Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
  • Главные ошибки при формировании базы данных в MS Excel
  • Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4

Галерея

20170802 170633
20180131 164914
20180131 155935
DJI 0034
20180131 135955
20180814 182629
  • Check Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-11-29 By FDA
  • Procedural advice for veterinary vaccine antigen master file (VAMF) certification
    Source: EMA - Regulatory and procedural guidelines (human and veterinary) Published on 2025-11-28
  • FluMist
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-11-28 By FDA
  • Procedural advice for vaccine platform technology master file (vPTMF) certification
    Source: EMA - Scientific guidelines (human and veterinary) Published on 2025-11-28
  • Guidance for stepwise PIPs (sPIPs)
    Source: EMA - Regulatory and procedural guidelines (human and veterinary) Published on 2025-11-28
  • QE3 Guideline for Extractables and Leachables: Supporting Documentation: Class 3 Leachable Monographs
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-11-28 By FDA
  • Q3E Guideline for Extractables and Leachables
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-11-28 By FDA
  • Human medicines European public assessment report (EPAR): Comirnaty, COVID-19 mRNA vaccine, Date of authorisation: 21/12/2020, Revision: 57, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-11-28
  • Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 60, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-11-28
  • Human medicines European public assessment report (EPAR): MenQuadfi, meningococcal group A, C, W-135 and Y conjugate vaccine, Date of authorisation: 18/11/2020, Revision: 24, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-11-28
  • Human medicines European public assessment report (EPAR): Kyprolis, carfilzomib, Date of authorisation: 19/11/2015, Revision: 21, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-11-28
  • Newly Added Guidance Documents
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-11-28 By FDA
  • Current Good Manufacturing Practice for Medical Gases
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-11-28 By FDA
  • Human medicines European public assessment report (EPAR): Bilprevda, denosumab, Date of authorisation: 17/09/2025, Revision: 1, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-11-28
  • PDUFA VIII: Fiscal Years 2028 – 2032
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-11-28 By FDA
Older posts
Тема: Scaffold от Danny Cooper.